Company Filing History:
Years Active: 2024
Title: Abdullah Saleh Alhomida: Innovator in Anti-Cancer Pharmaceuticals
Introduction: Abdullah Saleh Alhomida is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer treatments. His innovative work focuses on gold complexes that exhibit anti-cancer properties, showcasing his commitment to advancing medical science.
Latest Patents: Abdullah Saleh Alhomida holds a patent for an "Anti-cancer gold complex, process of synthesis and method of treatment thereof." This patent relates to anti-cancer pharmaceuticals and specifically addresses gold complexes with anti-cancer properties. The disclosure includes a pharmaceutical composition comprising these complexes, a process for synthesizing them, and a method for treating cancer. The complexes are designed to adopt a multi-target approach to cancer therapeutics by inducing cell apoptosis, cytotoxicity, mitochondrial membrane potential depolarization, and increasing reactive oxygen species in cancer cells.
Career Highlights: Abdullah Saleh Alhomida is affiliated with King Saud University, where he contributes to research and development in the field of pharmaceuticals. His work is characterized by a strong focus on innovative solutions to combat cancer, reflecting his dedication to improving patient outcomes.
Collaborations: Abdullah has collaborated with notable colleagues, including Haseeb Ahmad Khan and Ali Al-Hoshani. These partnerships enhance the research efforts and broaden the impact of their work in the pharmaceutical field.
Conclusion: Abdullah Saleh Alhomida is a key figure in the development of anti-cancer pharmaceuticals, with a notable patent that highlights his innovative approach to treatment. His contributions to the field are significant and demonstrate the potential of gold complexes in cancer therapy.